Senti Biosciences Holdings, Inc. (SNTI)
0.9317
-0.02
(-2.01%)
USD |
NASDAQ |
Jun 18, 16:00
0.9351
0.00 (0.00%)
After-Hours: 20:00
Senti Biosciences Holdings Accounts Payable (Quarterly) : 1.052M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.052M |
| December 31, 2025 | 2.943M |
| September 30, 2025 | 1.771M |
| June 30, 2025 | 1.02M |
| March 31, 2025 | 1.559M |
| December 31, 2024 | 1.454M |
| September 30, 2024 | 0.793M |
| June 30, 2024 | 1.181M |
| March 31, 2024 | 1.624M |
| December 31, 2023 | 1.25M |
| September 30, 2023 | 1.991M |
| Date | Value |
|---|---|
| June 30, 2023 | 2.585M |
| March 31, 2023 | 2.582M |
| December 31, 2022 | 1.37M |
| September 30, 2022 | 1.768M |
| June 30, 2022 | 5.755M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 5.187M |
| September 30, 2021 | 0.0001M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | 7.317M |
| Summit Therapeutics, Inc. | 27.55M |
| Kezar Life Sciences, Inc. | 0.273M |
| Protara Therapeutics, Inc. | 4.031M |